From Setbacks to Solutions: Pioneering Safe RSV Vaccines for Infants, Children

Sep 21

Written By Bluelake Biotechnology

article by founder Biao He in Pharmacy Times

Bluelake Biotechnology

Blue Lake Biotechnology Presenting at Upcoming BioFuture and BIO Investor Forum Conferences

Blue Lake Biotechnology Doses First Child in Clinical Trial of Novel Intranasal Vaccine Against Respiratory Syncytial Virus